Efficacy and safety of intravitreal injection of triamcinolone-moxifloxacin after cataract surgery in a low to middle income country – a one-year audit

Objective: To evaluate the safety and efficacy of intravitreal injection of triamcinolone and moxifloxacin regime administered immediately following cataract surgery. Method: The retrospective study was conducted from January to June 2021 at a tertiary care referral centre in Karachi and comprise...

Full description

Bibliographic Details
Main Authors: Irfan Kabiruddin Jeeva, Sidra Masud, Muhammad Abdul Rehman Siddiqui
Format: Article
Language:English
Published: Pakistan Medical Association 2022-12-01
Series:Journal of the Pakistan Medical Association
Online Access:https://www.ojs.jpma.org.pk/index.php/public_html/article/view/5207
_version_ 1797820975729868800
author Irfan Kabiruddin Jeeva
Sidra Masud
Muhammad Abdul Rehman Siddiqui
author_facet Irfan Kabiruddin Jeeva
Sidra Masud
Muhammad Abdul Rehman Siddiqui
author_sort Irfan Kabiruddin Jeeva
collection DOAJ
description Objective: To evaluate the safety and efficacy of intravitreal injection of triamcinolone and moxifloxacin regime administered immediately following cataract surgery. Method: The retrospective study was conducted from January to June 2021 at a tertiary care referral centre in Karachi and comprised record of all patients who underwent dropless cataract surgery from April 2018 to June 2019. Data included slit lamp examination, dilated fundal exam, uncorrected visual acuity, best corrected visual acuity, and intraocular pressure. Cataract assessment and anterior chamber reaction were graded according to the World Health Organisation cataract grouping system. Efficacy of the regime was defined as the ability to prevent postoperative endophthalmitis. Stratification analysis was done to note if gender has any role in terms of effectiveness. Data was analysed using Microsoft Excel version 16.0 and IBM SPSS version 27. Results: Of 240 eyes of 161 patients analysed, 114(47.5%) were of men who had a mean age of 57.89±14.32 years, and 126(52.5%) were of females with a mean age of 58.02±10.85 years. Overall, 2(1.75%) male subjects and 1(0.8%) female subject developed breakthrough inflammation within one week of the procedure. They were treated with anti-inflammatory drops and in 1(33%) of the cases antibiotic drop for 1 week. At day 90, no patient had residual inflammation or new onset inflammation. Also, 15(6.25%) patients developed raised intraocular pressure from day 7 to day 30. Most cases 10(66.7%) resolved within 1 week of using intraocular pressure-lowering drops. No patient developed endophthalmitis postoperatively. Conclusion: Dropless cataract regime was found to be an effective and safe alternative that was easy to administer9. Key Words: Dropless cataract surgery, Safety of cataract surgery, Innovations in cataract surgery, Endophthalmitis after dropless.
first_indexed 2024-03-13T09:46:03Z
format Article
id doaj.art-ed0964af9b6645558495fb64d61ded1f
institution Directory Open Access Journal
issn 0030-9982
language English
last_indexed 2024-03-13T09:46:03Z
publishDate 2022-12-01
publisher Pakistan Medical Association
record_format Article
series Journal of the Pakistan Medical Association
spelling doaj.art-ed0964af9b6645558495fb64d61ded1f2023-05-25T04:21:15ZengPakistan Medical AssociationJournal of the Pakistan Medical Association0030-99822022-12-0173110.47391/JPMA.5207Efficacy and safety of intravitreal injection of triamcinolone-moxifloxacin after cataract surgery in a low to middle income country – a one-year auditIrfan Kabiruddin Jeeva0Sidra Masud1Muhammad Abdul Rehman Siddiqui2Department of Ophthalmology, Aga Khan University Hospital, Karachi, PakistanDepartment of Ophthalmology, Aga Khan University Hospital, Karachi, PakistanDepartment of Ophthalmology, Aga Khan University Hospital, Karachi, Pakistan Objective: To evaluate the safety and efficacy of intravitreal injection of triamcinolone and moxifloxacin regime administered immediately following cataract surgery. Method: The retrospective study was conducted from January to June 2021 at a tertiary care referral centre in Karachi and comprised record of all patients who underwent dropless cataract surgery from April 2018 to June 2019. Data included slit lamp examination, dilated fundal exam, uncorrected visual acuity, best corrected visual acuity, and intraocular pressure. Cataract assessment and anterior chamber reaction were graded according to the World Health Organisation cataract grouping system. Efficacy of the regime was defined as the ability to prevent postoperative endophthalmitis. Stratification analysis was done to note if gender has any role in terms of effectiveness. Data was analysed using Microsoft Excel version 16.0 and IBM SPSS version 27. Results: Of 240 eyes of 161 patients analysed, 114(47.5%) were of men who had a mean age of 57.89±14.32 years, and 126(52.5%) were of females with a mean age of 58.02±10.85 years. Overall, 2(1.75%) male subjects and 1(0.8%) female subject developed breakthrough inflammation within one week of the procedure. They were treated with anti-inflammatory drops and in 1(33%) of the cases antibiotic drop for 1 week. At day 90, no patient had residual inflammation or new onset inflammation. Also, 15(6.25%) patients developed raised intraocular pressure from day 7 to day 30. Most cases 10(66.7%) resolved within 1 week of using intraocular pressure-lowering drops. No patient developed endophthalmitis postoperatively. Conclusion: Dropless cataract regime was found to be an effective and safe alternative that was easy to administer9. Key Words: Dropless cataract surgery, Safety of cataract surgery, Innovations in cataract surgery, Endophthalmitis after dropless. https://www.ojs.jpma.org.pk/index.php/public_html/article/view/5207
spellingShingle Irfan Kabiruddin Jeeva
Sidra Masud
Muhammad Abdul Rehman Siddiqui
Efficacy and safety of intravitreal injection of triamcinolone-moxifloxacin after cataract surgery in a low to middle income country – a one-year audit
Journal of the Pakistan Medical Association
title Efficacy and safety of intravitreal injection of triamcinolone-moxifloxacin after cataract surgery in a low to middle income country – a one-year audit
title_full Efficacy and safety of intravitreal injection of triamcinolone-moxifloxacin after cataract surgery in a low to middle income country – a one-year audit
title_fullStr Efficacy and safety of intravitreal injection of triamcinolone-moxifloxacin after cataract surgery in a low to middle income country – a one-year audit
title_full_unstemmed Efficacy and safety of intravitreal injection of triamcinolone-moxifloxacin after cataract surgery in a low to middle income country – a one-year audit
title_short Efficacy and safety of intravitreal injection of triamcinolone-moxifloxacin after cataract surgery in a low to middle income country – a one-year audit
title_sort efficacy and safety of intravitreal injection of triamcinolone moxifloxacin after cataract surgery in a low to middle income country a one year audit
url https://www.ojs.jpma.org.pk/index.php/public_html/article/view/5207
work_keys_str_mv AT irfankabiruddinjeeva efficacyandsafetyofintravitrealinjectionoftriamcinolonemoxifloxacinaftercataractsurgeryinalowtomiddleincomecountryaoneyearaudit
AT sidramasud efficacyandsafetyofintravitrealinjectionoftriamcinolonemoxifloxacinaftercataractsurgeryinalowtomiddleincomecountryaoneyearaudit
AT muhammadabdulrehmansiddiqui efficacyandsafetyofintravitrealinjectionoftriamcinolonemoxifloxacinaftercataractsurgeryinalowtomiddleincomecountryaoneyearaudit